Retinopathy of Prematurity

On this page

ROP: Intro & Pathophysiology - Preemie Eye Peril

  • Definition: Proliferative retinopathy in premature, low birth weight (LBW) infants due to incomplete retinal vascularization.
  • Pathophysiology: Biphasic process.
    • Phase 1 (Hyperoxic/Vaso-cessation): Postnatal ↑O₂ (esp. therapy) → ↓VEGF → delayed normal vessel growth, potential vaso-obliteration.
    • Phase 2 (Hypoxic/Vasoproliferative): Expanding avascular retina → relative hypoxia → ↑VEGF → abnormal neovascularization at vascular/avascular junction.
  • Key Risk Factors:
    • Prematurity: Gestational Age (GA) < 32 weeks
    • LBW: Birth Weight (BW) < 1500g
    • Oxygen therapy (duration, concentration fluctuations)
    • Sepsis, poor postnatal weight gain, blood transfusions. Retinopathy of Prematurity Pathophysiology

⭐ The temporal retina is most commonly affected and is the last to complete vascularization, making it particularly vulnerable in ROP development.

ROP: Classification - Mapping the Mayhem

ICROP classification:

  • Zones (Location): Extent from optic disc.
    • Zone I: Posterior pole; radius 2x disc-macula distance. Poorest prognosis.
    • Zone II: Zone I edge to nasal ora serrata & temporal equator.
    • Zone III: Remaining anterior temporal crescent. ROP Zone Classification Diagram
  • Stages (Severity): Neovascularization degree.
    • Stage 1: Demarcation Line.
    • Stage 2: Ridge.
    • Stage 3: Ridge + extraretinal fibrovascular proliferation (mild/mod/sev).
    • Stage 4: Partial Retinal Detachment (RD) (4A: extrafoveal; 4B: foveal).
    • Stage 5: Total RD (funnel).
  • Plus Disease ("+"): Vascular dilation & tortuosity (≥2 posterior quadrants). Active, severe ROP.

    ⭐ Plus disease is a critical indicator for treatment.

  • AP-ROP (Aggressive Posterior ROP): Rapid, severe; Zone I/posterior Zone II. Prominent plus disease.
  • Pre-Plus: Abnormal vessels, not yet Plus disease criteria met.

ROP: Screening Guidelines - Catching It Early

  • Who to Screen:
    • Infants: Birth Weight (BW) < 1500g OR Gestational Age (GA) ≤ 32 weeks.
    • Selected infants: BW 1500-2000g or GA > 32 weeks with risk factors like prolonged oxygen therapy, sepsis, intraventricular hemorrhage, or significant cardiorespiratory compromise.
  • When to Screen (First Exam):
    • Perform at 4 weeks chronological age (CA) OR 31 weeks post-conceptional age (PCA = GA + CA), whichever is later.
      • 📌 Mnemonic: "4-31 Rule".
    • Crucial for timely detection of treatable ROP.

⭐ Plus Disease: Marked by venous dilation and arteriolar tortuosity in at least two posterior pole quadrants. Its presence signifies severe ROP and often necessitates prompt treatment.

ROP: Management & Treatment - Saving Tiny Sight

  • Goal: Prevent retinal detachment & blindness.

  • Screening: Crucial for timely intervention.

  • Treatment Criteria (ETROP Study):

    • Type 1 ROP: High-risk prethreshold ROP requiring treatment.
      • Zone I, any stage ROP with plus disease.
      • Zone I, stage 3 ROP, no plus disease.
      • Zone II, stage 2 or 3 ROP with plus disease.
    • Type 2 ROP: Lower risk, observe closely.
  • Treatment Modalities:

    • Laser Photocoagulation: Ablate avascular retina. Standard of care.
      • Indication: Type 1 ROP.
      • Timing: Within 72 hours of diagnosis.
    • Anti-VEGF (Bevacizumab, Ranibizumab): Intravitreal injection.
      • Indication: Primarily for Zone I ROP (especially posterior/AP-ROP).
      • ⚠️ Potential for late recurrence; long-term systemic effects unclear.
    • Vitreoretinal Surgery: For retinal detachment (Stage 4 & 5).
  • Complications of Treatment:

    • Laser: Myopia, astigmatism, cataract, visual field defects.
    • Anti-VEGF: Endophthalmitis (rare), ROP recurrence.

⭐ Bevacizumab is often preferred for aggressive posterior ROP (AP-ROP) due to its ability to rapidly control neovascularization.

  • Follow-up: Lifelong, due to risks of strabismus, amblyopia, myopia, glaucoma, late detachment. 📌 ROP needs Regular Ophthalmic Patrol.

High‑Yield Points - ⚡ Biggest Takeaways

  • ROP is a proliferative retinopathy in premature infants (<1500g, <32 weeks), linked to oxygen therapy.
  • Key pathology: biphasic - initial vaso-cessation (hyperoxia), then vaso-proliferation (hypoxia).
  • Screening starts at 4 weeks postnatal or 31 weeks postconceptional age.
  • Plus disease (vascular dilation/tortuosity) indicates severe, active ROP.
  • Laser photocoagulation is standard for Type 1 ROP; anti-VEGF is an option.
  • Most common site: avascular temporal retinal periphery.
  • Long-term risks: myopia, strabismus, retinal detachment.

Practice Questions: Retinopathy of Prematurity

Test your understanding with these related questions

Optic disc changes of retinitis pigmentosa:

1 of 5

Flashcards: Retinopathy of Prematurity

1/10

Retinopathy of prematurity (ROP), previously known as retrolental fibroplasia, is a disease of the eye that affects _____ babies.

TAP TO REVEAL ANSWER

Retinopathy of prematurity (ROP), previously known as retrolental fibroplasia, is a disease of the eye that affects _____ babies.

prematurely born

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial